113 related articles for article (PubMed ID: 34514913)
21. Beneficial Effect of a Fermented Wheat Germ Extract in Intestinal Epithelial Cells in case of Lipopolysaccharide-Evoked Inflammation.
Karancsi Z; Móritz AV; Lewin N; Veres AM; Jerzsele Á; Farkas O
Oxid Med Cell Longev; 2020; 2020():1482482. PubMed ID: 32849997
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant fermented wheat germ extract (Avemar) nutraceutical improves survival of high-risk skin melanoma patients: a randomized, pilot, phase II clinical study with a 7-year follow-up.
Demidov LV; Manziuk LV; Kharkevitch GY; Pirogova NA; Artamonova EV
Cancer Biother Radiopharm; 2008 Aug; 23(4):477-82. PubMed ID: 18771352
[TBL] [Abstract][Full Text] [Related]
23. Limonin suppresses the progression of oral tongue squamous cell carcinoma via inhibiting YAP transcriptional regulatory activity.
Yang G; Li Z; Chen L
Tissue Cell; 2020 Aug; 65():101346. PubMed ID: 32746992
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin K is present in invasive oral tongue squamous cell carcinoma in vivo and in vitro.
Bitu CC; Kauppila JH; Bufalino A; Nurmenniemi S; Teppo S; Keinänen M; Vilen ST; Lehenkari P; Nyberg P; Coletta RD; Salo T
PLoS One; 2013; 8(8):e70925. PubMed ID: 23951042
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
[TBL] [Abstract][Full Text] [Related]
26. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
[TBL] [Abstract][Full Text] [Related]
27. Detection of herpes simplex virus in oral tongue squamous cell carcinoma.
Koivikko T; Rodrigues PC; Vehviläinen M; Hyvönen P; Sundquist E; Arffman RK; Al-Samadi A; Välimaa H; Salo T; Risteli M
Front Pharmacol; 2023; 14():1182152. PubMed ID: 37234716
[No Abstract] [Full Text] [Related]
28. CXC chemokine‑7 inhibits growth and migration of oral tongue squamous cell carcinoma cells, mediated by the epithelial‑mesenchymal transition signaling pathway.
Liu TJ; Guo JL; Xu X
Mol Med Rep; 2017 Nov; 16(5):6896-6903. PubMed ID: 28901471
[TBL] [Abstract][Full Text] [Related]
29. Artesunate targets oral tongue squamous cell carcinoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
Xiao Q; Yang L; Hu H; Ke Y
J Bioenerg Biomembr; 2020 Apr; 52(2):113-121. PubMed ID: 31965456
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
31. Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer.
Li H; Zhang J; Chen SW; Liu LL; Li L; Gao F; Zhuang SM; Wang LP; Li Y; Song M
J Transl Med; 2015 Jun; 13():198. PubMed ID: 26094024
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma.
Wen H; Chen Y; Hu Z; Mo Q; Tang J; Sun C
Oncol Rep; 2014 Jan; 31(1):169-74. PubMed ID: 24252932
[TBL] [Abstract][Full Text] [Related]
33. Role of plasminogen activator inhibitor-1 in oral tongue squamous cell carcinoma: An immunohistochemical and in vitro analysis.
Mafra RP; Sabino VG; Rolim LSA; de Carvalho CHP; Nonaka CFW; Barboza CAG; de Souza LB; Pinto LP
Exp Mol Pathol; 2022 Feb; 124():104722. PubMed ID: 34800515
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
[TBL] [Abstract][Full Text] [Related]
35. Semaphorin-7A contributes to growth, migration and invasion of oral tongue squamous cell carcinoma through TGF-β-mediated EMT signaling pathway.
Liu TJ; Guo JL; Wang HK; Xu X
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1035-1043. PubMed ID: 29509252
[TBL] [Abstract][Full Text] [Related]
36. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
Åström P; Juurikka K; Hadler-Olsen ES; Svineng G; Cervigne NK; Coletta RD; Risteli J; Kauppila JH; Skarp S; Kuttner S; Oteiza A; Sutinen M; Salo T
Br J Cancer; 2017 Sep; 117(7):1007-1016. PubMed ID: 28772283
[TBL] [Abstract][Full Text] [Related]
37. Chloroform Extract of Solanum lyratum Induced G0/G1 Arrest via p21/p16 and Induced Apoptosis via Reactive Oxygen Species, Caspases and Mitochondrial Pathways in Human Oral Cancer Cell Lines.
Chiu CH; Chou YC; Lin JP; Kuo CL; Lu HF; Huang YP; Yu CC; Lin ML; Chung JG
Am J Chin Med; 2015; 43(7):1453-69. PubMed ID: 26477797
[TBL] [Abstract][Full Text] [Related]
38. The fatty acid synthase inhibitor orlistat reduces the growth and metastasis of orthotopic tongue oral squamous cell carcinomas.
Agostini M; Almeida LY; Bastos DC; Ortega RM; Moreira FS; Seguin F; Zecchin KG; Raposo HF; Oliveira HC; Amoêdo ND; Salo T; Coletta RD; Graner E
Mol Cancer Ther; 2014 Mar; 13(3):585-95. PubMed ID: 24362464
[TBL] [Abstract][Full Text] [Related]
39. Anti-Cancer Effects of Imperata cylindrica Leaf Extract on Human Oral Squamous Carcinoma Cell Line SCC-9 in Vitro.
Keshava R; Muniyappa N; Gope R; Ramaswamaiah AS
Asian Pac J Cancer Prev; 2016; 17(4):1891-8. PubMed ID: 27221872
[TBL] [Abstract][Full Text] [Related]
40. The effectiveness of fermented wheat germ extract as an adjunct therapy in the treatment of cancer: A systematic review.
Yeend T; Robinson K; Lockwood C; McArthur A
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
